Emulsion forming drug delivery system for lipophilic drugs
- PMID: 22568032
Emulsion forming drug delivery system for lipophilic drugs
Abstract
In the recent years, there is a growing interest in the lipid-based formulations for delivery of lipophilic drugs. Due to their potential as therapeutic agents, preferably these lipid soluble drugs are incorporated into inert lipid carriers such as oils, surfactant dispersions, emulsions, liposomes etc. Among them, emulsion forming drug delivery systems appear to be a unique and industrially feasible approach to overcome the problem of low oral bioavailability associated with the BCS class II drugs. Self-emulsifying formulations are ideally isotropic mixtures of oils, surfactants and co-solvents that emulsify to form fine oil in water emulsions when introduced in aqueous media. Fine oil droplets would pass rapidly from stomach and promote wide distribution of drug throughout the GI tract, thereby overcome the slow dissolution step typically observed with solid dosage forms. Recent advances in drug carrier technologies have promulgated the development of novel drug carriers such as control release self-emulsifying pellets, microspheres, tablets, capsules etc. that have boosted the use of "self-emulsification" in drug delivery. This article reviews the different types of formulations and excipients used in emulsion forming drug delivery system to enhance the bioavailability of lipophilic drugs.
Similar articles
-
Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).Drug Dev Ind Pharm. 2013 Jan;39(1):1-19. doi: 10.3109/03639045.2012.660949. Epub 2012 Feb 29. Drug Dev Ind Pharm. 2013. PMID: 22372916 Review.
-
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.Biomed Pharmacother. 2004 Apr;58(3):173-82. doi: 10.1016/j.biopha.2004.02.001. Biomed Pharmacother. 2004. PMID: 15082340 Review.
-
Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.Drug Discov Today. 2010 Nov;15(21-22):958-65. doi: 10.1016/j.drudis.2010.08.007. Epub 2010 Aug 17. Drug Discov Today. 2010. PMID: 20727418 Review.
-
The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations.J Pharm Pharmacol. 2004 Mar;56(3):307-16. doi: 10.1211/0022357022872. J Pharm Pharmacol. 2004. PMID: 15025855
-
Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.Acta Pharm. 2013 Dec;63(4):427-45. doi: 10.2478/acph-2013-0040. Acta Pharm. 2013. PMID: 24451070 Review.
Cited by
-
Electrospun Nanofibers: Shaping the Future of Controlled and Responsive Drug Delivery.Materials (Basel). 2023 Nov 7;16(22):7062. doi: 10.3390/ma16227062. Materials (Basel). 2023. PMID: 38004992 Free PMC article. Review.
-
Effects of Solvents, Emulsions, Cosolvents, and Complexions on Ex Vivo Mouse Myometrial Contractility.Reprod Sci. 2022 Feb;29(2):586-595. doi: 10.1007/s43032-021-00576-5. Epub 2021 Apr 14. Reprod Sci. 2022. PMID: 33852137 Free PMC article.
-
Nanoemulsion and Solid Nanoemulsion for Improving Oral Delivery of a Breast Cancer Drug: Formulation, Evaluation, and a Comparison Study.Saudi Pharm J. 2021 Nov;29(11):1278-1288. doi: 10.1016/j.jsps.2021.09.016. Epub 2021 Oct 8. Saudi Pharm J. 2021. PMID: 34819790 Free PMC article.
-
Optical Detection of Interleukin-6 Using Liquid Janus Emulsions Using Hyperthermophilic Affinity Proteins.ACS Omega. 2024 Aug 22;9(35):37076-37085. doi: 10.1021/acsomega.4c03959. eCollection 2024 Sep 3. ACS Omega. 2024. PMID: 39246480 Free PMC article.
-
Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.Pharmaceutics. 2022 Feb 27;14(3):533. doi: 10.3390/pharmaceutics14030533. Pharmaceutics. 2022. PMID: 35335909 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources